BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 12422152)

  • 21. The association between NT-proBNP levels, functional capacity and stage in patients with heart failure.
    Karabulut A; Kaplan A; Aslan C; Iltumur K; Toprak G; Toprak N
    Acta Cardiol; 2005 Dec; 60(6):631-8. PubMed ID: 16385925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea.
    Morrison LK; Harrison A; Krishnaswamy P; Kazanegra R; Clopton P; Maisel A
    J Am Coll Cardiol; 2002 Jan; 39(2):202-9. PubMed ID: 11788208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.
    Cheng V; Kazanagra R; Garcia A; Lenert L; Krishnaswamy P; Gardetto N; Clopton P; Maisel A
    J Am Coll Cardiol; 2001 Feb; 37(2):386-91. PubMed ID: 11216951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early diagnosis of congestive heart failure: clinical utility of B-type natriuretic peptide testing associated with Doppler echocardiography.
    Aspromonte N; Feola M; Scardovi AB; Coletta C; D'Eri A; Giovinazzo P; Carunchio A; Chiera A; Fanelli R; Di Giacomo T; Ricci R; Ceci V; Milani L; Valle R
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):406-13. PubMed ID: 16721202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
    Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
    J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bedside B-type natriuretic peptide and functional capacity in chronic heart failure.
    Jourdain P; Funck F; Bellorini M; Guillard N; Loiret J; Thebault B; Desnos M; Duboc D
    Eur J Heart Fail; 2003 Mar; 5(2):155-60. PubMed ID: 12644005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.
    Maeda K; Tsutamoto T; Wada A; Hisanaga T; Kinoshita M
    Am Heart J; 1998 May; 135(5 Pt 1):825-32. PubMed ID: 9588412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective clinical evaluation of an ELISA B-type natriuretic peptide assay in the diagnosis of congestive heart failure in dogs presenting with cough or dyspnea.
    DeFrancesco TC; Rush JE; Rozanski EA; Hansen BD; Keene BW; Moore DT; Atkins CE
    J Vet Intern Med; 2007; 21(2):243-50. PubMed ID: 17427384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure.
    Tjeerdsma G; de Boer RA; Boomsma F; van den Berg MP; Pinto YM; van Veldhuisen DJ
    Int J Cardiol; 2002 Dec; 86(2-3):143-9; discussion 149-52. PubMed ID: 12419550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.
    Kazanegra R; Cheng V; Garcia A; Krishnaswamy P; Gardetto N; Clopton P; Maisel A
    J Card Fail; 2001 Mar; 7(1):21-9. PubMed ID: 11264546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study.
    McCullough PA; Duc P; Omland T; McCord J; Nowak RM; Hollander JE; Herrmann HC; Steg PG; Westheim A; Knudsen CW; Storrow AB; Abraham WT; Lamba S; Wu AH; Perez A; Clopton P; Krishnaswamy P; Kazanegra R; Maisel AS;
    Am J Kidney Dis; 2003 Mar; 41(3):571-9. PubMed ID: 12612980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cut-off values of B-type natriuretic peptide for the diagnosis of congestive heart failure in patients with dyspnoea visiting emergency departments: a study on Korean patients visiting emergency departments.
    Choi S; Park D; Lee S; Hong Y; Kim S; Lee J
    Emerg Med J; 2007 May; 24(5):343-7. PubMed ID: 17452702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department.
    McCullough PA; Hollander JE; Nowak RM; Storrow AB; Duc P; Omland T; McCord J; Herrmann HC; Steg PG; Westheim A; Knudsen CW; Abraham WT; Lamba S; Wu AH; Perez A; Clopton P; Krishnaswamy P; Kazanegra R; Maisel AS;
    Acad Emerg Med; 2003 Mar; 10(3):198-204. PubMed ID: 12615582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study.
    McCullough PA; Nowak RM; McCord J; Hollander JE; Herrmann HC; Steg PG; Duc P; Westheim A; Omland T; Knudsen CW; Storrow AB; Abraham WT; Lamba S; Wu AH; Perez A; Clopton P; Krishnaswamy P; Kazanegra R; Maisel AS
    Circulation; 2002 Jul; 106(4):416-22. PubMed ID: 12135939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of B-type natriuretic peptide level to 6-min walk test performance in patients with left ventricular systolic dysfunction.
    Wieczorek SJ; Hager D; Barry MB; Kearney L; Ferrier A; Wu AH
    Clin Chim Acta; 2003 Feb; 328(1-2):87-90. PubMed ID: 12559602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes.
    Epshteyn V; Morrison K; Krishnaswamy P; Kazanegra R; Clopton P; Mudaliar S; Edelman S; Henry R; Maisel A
    Diabetes Care; 2003 Jul; 26(7):2081-7. PubMed ID: 12832317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation.
    Shimamoto K; Kusumoto M; Sakai R; Watanabe H; Ihara S; Koike N; Kawana M
    Can J Cardiol; 2007 Mar; 23(4):295-300. PubMed ID: 17380223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea.
    Logeart D; Saudubray C; Beyne P; Thabut G; Ennezat PV; Chavelas C; Zanker C; Bouvier E; Solal AC
    J Am Coll Cardiol; 2002 Nov; 40(10):1794-800. PubMed ID: 12446063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.